Biosimilars
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
36
NCT06732583
A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years
Phase: Phase 1
Role: Collaborator
Start: Feb 28, 2025
Completion: Aug 31, 2025
Loading map...